tirzepatide body 43 pounds down—and this is exactly how works 👇🏼✨ Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors to help: ✔️ Reduce appetite and cravings ✔️ Slow gastric AMRA Used in Tirzepatide Analyses

Hu X, Yang P, Chai C, Liu J, Sun H, Wu Y, et al

Effects of GLP-1 agonists on vascular endothelium Enhancing endothelial function A review of the literature revealed multiple preclinical studies on GLP-1R agonists in animal models demonstrating the molecular mechanisms behind their pharmacological effects

You can expect the results to last for at least six months

Type 2 diabetes Treatment summaries, BNF NICE

It has been suggested that excess copper may increase the free radical content and aggravate the occurrence of diseases such as aging and malignancy

A separate JAMA Health Forum analysis found semaglutide would need a very large price reduction to meet common cost-effectiveness thresholds, and tirzepatide would also require further price cuts to become cost-effective in that model